Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
A 25-year-old restrained male driver involved in a rollover motor vehicle accident presents acutely for repair of bilateral open tibia fractures. Loss of consciousness was reported at the scene. The patient is currently alert but disoriented, with a Glasgow Coma Scale score on examination of 14. He also exhibits slurred speech and injected conjunctivae. He admits to ingestion of alcohol and amphetamines just before the accident. He is stable hemodynamically, and a thorough trauma evaluation is undertaken after completion of the primary and secondary surveys (including a negative computed tomography [CT] scan of the head, cervical spine, chest, abdomen, and pelvis), making other significant injuries much less likely. Other findings are as follows: blood pressure 110/50 mm Hg, pulse 124 beats per minute, respiratory rate 24 breaths per minute, temperature 37.1°C, and pulse oximetry 100% on room air. Significant laboratory findings include hematocrit 24%, pH 7.27, base deficit of −10 mEq/L, and blood alcohol content 279 mg/dL.
Exposure to toxic substances occurs commonly, as evidenced by the 3.1 million calls received by poison control centers in 2013. Such calls typically involved an acute (88%), unintentional (80%), oral (79%) exposure to a single toxin (89%) by a child (57%) at a private residence (91%). Although almost 70% of such cases in 2013 were managed outside the health care system, toxic ingestions still resulted in 601,642 physician visits, 228,230 hospital admissions, 99,117 critical care admissions, and 2113 deaths. These data are even more impressive given that poison control center information likely underestimates the true incidence of both toxic exposure and adverse poisoning outcomes due to underreporting. Drug classes associated with the largest number of deaths in 2013 (in descending order of frequency) were analgesics, stimulant/street drugs (heroin, methamphetamine, and cocaine), cardiovascular drugs, antidepressants, and sedatives/hypnotics/antipsychotics.
Most poisoning ingestions tend to follow one of two general patterns. Children (<12 years of age) usually take small quantities of a single toxin unintentionally and seldom manifest significant morbidity or mortality. In contrast, adolescents and adults typically ingest larger amounts of multiple toxins intentionally and suffer higher rates of morbidity and mortality.
Large series of mixed adult overdoses suggest that the coingestion of ethanol occurs in approximately 50% of cases, and alcohol significantly confounds the initial clinical assessment in a similar percentage of trauma patients. Ethanol-related motor vehicle accidents in the United States during 2013 caused nearly one-third (31%) of all traffic-related deaths and resulted in an associated cost of over $59 billion. To complicate things, drugs other than alcohol are reportedly involved in approximately 18% of motor vehicle driver deaths.
The clinician should therefore maintain a high index of suspicion that adolescent and adult trauma victims have some form of acute intoxication and should evaluate the patient for evidence of substance abuse during the initial history, physical examination, and diagnostic workup. Important historical data include the specific toxin or toxins, quantity taken, ingestion time, signs and symptoms since ingestion, past medical and psychiatric history (including suicidal intent), current medications, allergies, and trauma (accidental, incidental, or self-inflicted). Because the history can often be unreliable or incomplete in acute poisoning situations, supplemental data from other sources (e.g., public safety personnel, family, medical records, area pharmacies, local poison control centers, state narcotic databases) may be helpful in diagnosing toxic exposures. A rapid, systematic, and thorough physical examination is mandatory, given the vague history that often surrounds poisoning and trauma scenarios. Barrier precautions should be exercised where appropriate to prevent self-intoxication (such as cutaneous exposure to organophosphate insecticides). The assessment should initially focus on the ABCs (airway, breathing, and circulation), with aggressive intervention to stabilize any abnormalities discovered. Additional assessment considerations are as follows:
Gag reflex. This has implications for airway protection and possible aspiration in overdose patients, but contributes little to clinician assessment and the Glasgow Coma Scale regarding the possible need for intubation.
Core temperature disturbances. Multiple etiologies may be involved, including toxic (salicylates, stimulants), environmental, and/or infectious causes.
Neurologic examination abnormalities. Detection of central nervous system dysfunction (such as confusion, coma, or delirium) should prompt the clinician to pursue additional diagnostic imaging such as CT or magnetic resonance imaging to evaluate for other potential causes such as cervical spinal cord injury, ischemic stroke, or intracranial hemorrhage.
Incidental trauma and stigmata of substance abuse. The patient should be examined for puncture wounds, needle tracks, and nasal septal perforation.
Constellation of signs and symptoms (“toxidromes”). The ingestion of certain toxins may present as characteristic toxidromes typically involving abnormal vital signs, altered mental status, pupillary changes, and a variety of miscellaneous effects that can be attributed to the known pharmacologic properties of the particular drug class. Examples of specific toxidromes are provided in Table 80.1 .
Syndrome | Common Clinical Signs | Potential Toxic Agents |
---|---|---|
Anticholinergic | Tachycardia, fever, dry skin, urinary retention, ileus, mydriasis, delirium, seizures | Antihistamines, phenothiazines, tricyclic antidepressants, antipsychotics, atropine, scopolamine, jimsonweed, amantadine, antiparkinson drugs, Amanita mushrooms, baclofen |
Cholinergic | Bradycardia, diaphoresis, urinary or fecal incontinence, emesis, miosis, central nervous system depression, weakness, fasciculations, wheezing | Organophosphate and carbamate insecticides, physostigmine, pyridostigmine, edrophonium, certain mushrooms |
Sympathomimetic (stimulants) | Tachycardia (bradycardia with pure α-agonist), hypertension, mydriasis, diaphoresis, piloerection, fever, delusions, paranoid ideation, restlessness, agitation | Cocaine, amphetamines, over-the-counter decongestants (pseudoephedrine, phenylpropanolamine, phenylephrine) |
Narcotic | Mental status depression, hypoventilation, miosis, ileus, hypotension, bradycardia | Opioids |
Sedative-hypnotic | Confusion, slurred speech, mental status depression, respiratory depression, ataxia, hypothermia | Benzodiazepines, barbiturates, ethanol, antipsychotics, anticonvulsants |
Serotonin | Fever, diaphoresis, flushing, diarrhea, hyperreflexia, tremor, myoclonus, trismus | Selective serotonin reuptake inhibitors, trazodone, clomipramine, meperidine, methadone, dextromethorphan, linezolid, tramadol, others. |
Hallucinogenic | Hallucinations, psychosis, paranoid ideation, panic, fever, mydriasis | Cocaine, amphetamines, cannabinoids, phencyclidine (PCP), lysergic acid diethylamide (LSD), antihistamines |
Extrapyramidal | Tremor, rigidity, opisthotonos, torticollis, choreoathetosis, trismus, hyperreflexia | Typical and atypical antipsychotics |
Laboratory evaluation should be based on the suspected ingestion (i.e., drug levels, blood alcohol level) and should include consideration of acetaminophen and salicylate levels in overdose situations. Urine drug screens may occasionally provide diagnostic clues about possible ingestions, although results are typically not available in a timely manner, and the substances detected will vary between institutions.
Concomitant trauma and poisoning may confound the accurate assessment of each individual entity, as exemplified by the case synopsis. Normal blood pressure and pulse pressure in the presence of anemia, tachycardia, and metabolic acidosis likely reflects hypovolemic shock that is partially masked by amphetamine-associated vasoconstriction.
The vast majority of acutely poisoned patients have satisfactory outcomes when given appropriate supportive care, with an emphasis on aggressive, early intervention to stabilize vital organ function. Initial efforts should focus on maintaining a stable, patent airway, establishing adequate ventilation and oxygenation, and stabilizing cardiovascular function, just as one would do for other medical emergencies. All patients with depressed mental status should receive oxygen if hypoxia is present, consideration of intravenous naloxone if there is clinical concern for opioid overdose, and intravenous dextrose if the finger-stick blood glucose level is low. Hypoglycemia should be corrected as early as possible even in patients with suspected thiamine deficiency, as recent literature does not support the classical practice of thiamine administration before glucose to avoid precipitating Wernicke’s encephalopathy. Tonic-clonic seizures that are suspected to be the result of a toxin or drug are best treated with benzodiazepines, often at higher doses than those required for traditional epileptic seizures. Intravenous barbiturates are acceptable second-line agents given their γ-aminobutyric acid (GABA)–agonist activity. Given the high incidence of ethanol abuse in both poisoning and trauma patients, early monitoring for alcohol withdrawal should be implemented with appropriate initiation of benzodiazepine therapy as indicated.
Definitive poisoning management typically involves the early use of specific antidotes (where appropriate) and decontamination techniques. Gastrointestinal decontamination primarily revolves around activated charcoal, which should be considered for potentially toxic ingestions of agents known to adsorb to charcoal. It should be administered as early as possible (ideally within 1 hour of ingestion) and only in patients who have an appropriate mental status or secured airway. Repeat dosing of charcoal is currently recommended only in patients who have ingested life-threatening amounts of carbamazepine, dapsone, phenobarbital, quinine, or theophylline. Repeat charcoal dosing for aspirin overdose remains controversial, but may be considered by the clinician. Other more historical decontamination techniques such as gastric emptying (using either syrup of ipecac or gastric lavage) and decreasing intestinal transit time using osmotic cathartics have continued to fall out of favor due to persistent absence of evidence-based literature support. Syrup of ipecac administration has been completely abandoned, and the risks of gastric lavage limit its utilization to extremely rare situations of massive enteral overdoses where skilled personnel with proper training and experience in this therapy are present to initiate it early after ingestion. Evidence supporting whole bowel irrigation using large volumes of isosmotic cathartics is also weak, but it may be considered for ingestions involving enteric-coated/sustained-released medications, illicit drug packets, or substances not adsorbed to activated charcoal (e.g., lithium, iron, potassium). Hemodialysis is reserved for dialyzable toxins with clinically significant effects or levels (e.g. salicylates, lithium, metformin). ( Table 80.2 ; Boxes 80.1 and 80.2 ).
Toxin | Antidote |
---|---|
Opiates | Naloxone |
Benzodiazepines | Flumazenil (beware of precipitating seizures in patients taking chronic benzodiazepines) |
Anticholinergics | Physostigmine (in consultation with a Toxicologist) |
Cholinesterase inhibitors | Atropine, pralidoxime (for insecticides) |
Calcium channel blockers | Calcium chloride, glucagon, consider high dose insulin therapy |
β-Blockers | Glucagon, consider high dose insulin therapy |
Digoxin | Digoxin-specific antibody |
Acetaminophen | N -acetylcysteine |
Methanol | Fomepizole, ethanol |
Ethylene glycol | Fomepizole, ethanol |
Isoniazid | Pyridoxine |
Cyanide | Amyl nitrate, sodium nitrite, sodium thiosulfate, hydroxocobalamin |
Methemoglobin | Methylene blue |
Iron | Deferoxamine |
Single dose: Ingestions of drugs or toxins that bind to activated charcoal, when no contraindications exist and an improved outcome is expected.
Multiple doses: Ingestions of drugs or toxins that bind to activated charcoal and (1) a prolonged absorption phase is expected, (2) potential toxicity is great, and (3) patient has ingested life-threating amounts of carbamazepine, dapsone, phenobarbital, quinine, or theophylline. Repeat dosing for aspirin overdose remains controversial.
Become a Clinical Tree membership for Full access and enjoy Unlimited articles
If you are a member. Log in here